IBM INTERNATIONAL BUSINESS MACHINES CORP Insider Trading

Director Michelle J Howard buys 50 IBM shares at $237.83, increasing stake 34.7% to 194 shares

Director Michelle J Howard purchased 50 shares of IBM at $237.83 on 2026-02-25, a discretionary acquisition that increased her holdings by 34.7% from 144 to 194 shares. The purchase occurred at a price notably below the 52-week high of $314.98, as the stock has declined -24.6% from that peak and -19.8% over the prior 30 days. IBM's fundamentals remain solid with $16.3B in quarterly revenue, net income of $1.7B, annual revenue growth of +7.6%, and a P/E of 17.86, suggesting the company is profitable and growing despite recent price weakness. The director's choice to substantially increase holdings during a period of stock depreciation may warrant attention to her rationale, though the transaction alone does not definitively signal confidence or concern absent additional context.

Director Miebach Michael bought 434 IBM shares at $233.33 on 2026-02-25 ($101.3K), initiating a position as stock trades near 24.6% below 52-week high.

Miebach Michael, an IBM director, purchased 434 shares at $233.33, establishing an initial open-market position of 434 shares. The transaction occurred when IBM stock is trading at $237.54, down 24.6% from its 52-week high of $314.98 and declining 19.8% over the prior 30 days. Across his complete trading history spanning all tickers, this insider's prior sells show a 45.00% well-timed rate with an average 90-day return of -0.7%, suggesting modest accuracy in exit timing but no strong pattern of prescient trading. The buy occurs against a backdrop of deteriorating near-term price momentum and a valuation that reflects substantial recent weakness, though IBM's underlying fundamentals remain solid with annual revenue growth of 7.6%, a P/E of 17.86, and a $222.8B market cap.

Director David Farr buys 1,000 IBM shares at $304.00; post-transaction holdings 9,258 shares (+12.1%)

Director David N Farr purchased 1,000 shares of IBM at $304.00 on 2026-01-30, increasing his holdings by 12.1% from 8,258 to 9,258 shares. Farr's cross-ticker track record shows 1 prior buy with a 90-day win rate of 100.00%, and his only prior IBM transaction (buy on 2025-02-28) yielded a +3.9% 90-day return, aligning with a pattern of well-timed entry points. IBM is trading at $306.70 with a 30-day return of +3.5%, slightly below its 52-week high of $314.98 (-2.6%). The purchase occurs amid IBM's strong recent momentum and at a company level marked by solid quarterly fundamentals (Net income $1.7B on $16.3B quarterly revenue).

SVP Thomas Robert David sold 26,543 IBM shares at $253.01 for $6.7M, reducing holdings 37.1%.

Thomas Robert David sold 26,543 shares (26.5K shares) at $253.01 on 2025-03-03, a substantial reduction of 37.1% from his pre-transaction holdings of 71,550 shares. The sale occurred at $253.01 per share while IBM's current price stands at $250.19, indicating the transaction executed near recent price levels but -5.5% from the 52-week high of $264.74. Despite the recent 90-day rally of +9.2%, IBM faces fundamental headwinds with reported net income of -$330.0M in the latest quarter against revenue of $15.0B, and a strained P/E of 47.21 paired with only 1.4% annual revenue growth. The scale of the reduction in David's personal holdings—from 71.6K to 45.0K shares—represents a material change in his disclosed position and warrants examination of the specific context in which this sale occurred.

IBM Director David N. Farr bought 1,200 shares ($298,800) at $249.00; holds 8,258 shares post-transaction.

David N. Farr, an IBM Director, purchased 1,200 shares at $249.00 on 2025-02-28, increasing his holdings from 7,058 to 8,258 shares (+17.0% relative to pre-transaction holdings). The transaction occurred at a price $3.44 below the current level of $252.44 and within the 52-week range. IBM's recent fundamentals show Net income of $-330,000,000.00 against Revenue of $14,968,000,000.00 (latest quarter), with a P/E of 47.63 and annual revenue growth of +1.4%. The stock has risen 10.4% over 30 days and 11.0% over 90 days despite trading at -4.6% from its 52-week high of $264.74. The purchase represents a modest absolute addition to his registered holdings in the context of IBM's $234.1B market cap.

Director Alfred W. Zollar buys 936 IBM shares at $210.62; first purchase; stock -10.4% from 52-week high

Alfred W. Zollar, a director of IBM, made an open-market purchase of 936 shares at $210.62 on 2024-11-13, totaling $197,138.92, establishing his first recorded shareholding in the company. The purchase occurs as IBM trades at $210.92, down 10.4% from its 52-week high of $235.26 and down 10.4% over the past 30 days, though up 8.8% over 90 days. IBM's recent fundamentals show net income of -$330.0M against quarterly revenue of $15.0B, with a P/E of 30.48 and market cap of $195.0B. A director's initial share purchase in a large-cap technology company at a depressed level from recent highs may reflect selective allocation, though with only one prior buy across his entire cross-ticker track record, the transaction size and pattern do not yet establish a sustained conviction signal.

SVP Lamoreaux sold 3,600 IBM shares at $215.20 on 2024-11-08; retains 25,389 shares post-transaction.

Senior Vice President Jaclyn Lamoreaux sold 3,600 shares at $215.20, reducing her holdings by 12.4% to 25,389 shares remaining. The sale occurred when IBM's stock was trading near its 52-week high of $235.26 and has since declined 9.2% to the current price of $213.72, with a 30-day decline of 8.8%. IBM's fundamentals show revenue of $14,968,000,000.00 in the latest quarter and negative net income of $-330,000,000.00, alongside a P/E of 30.88 and annual revenue growth of 2.2%. The transaction is sized as a modest partial reduction of a substantial executive position held by a senior officer.